Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia
Technology Appraisal Guidance No. 193 Source: National Institute for Health and...
Jump to:
MIMS, or the Monthly Index of Medical Specialities, has been providing healthcare professionals with information on prescription medicines every month since its launch in 1959.
MIMS publications are independently compiled by our editorial team and are widely used by healthcare professionals in particular general practitioners, pharmacists and nurse prescribers.
See below for details of our latest MIMS publications including how to obtain your copies.
Technology Appraisal Guidance No. 192 Source: National Institute for Health and...
Technology Appraisal Guidance No. 193 Source: National Institute for Health and...
Technology Appraisal Guidance No. 191 Source: National Institute for Health and...
Technology Appraisal Guidance No. 190 Source: National Institute for Health and...
Technology Appraisal Guidance No. 188 Source: National Institute for Health and...
Educational resource for the learning and teaching of the
GP curriculum
Cumulative list of products discontinued from the UK market
in 2010
Healthcare Republic resource centre for diagnosing and managing psoriasis
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.